NeoGenomics Has Attractive Charts and Should Continue Its Uptrend
Let's see what the charts suggest.
The Charts of CVS Health Are Coming Out of Rehab
Let's check out the charts.
Interested in Health Catalyst? Be a Patient Buyer
Let's see if a little bit of price history can help us with a level to buy.
These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
These 2 Companies Could Be More Than Pet Projects for Investors
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
Johnson & Johnson Is in the News, but How Do the Charts Look?
I am not focused on today's price movement of the stock but the pattern from the end of 2017.
Amgen Charts Indicate Shares Want to Work Their Way Higher Longer Term
Amgen's deal to buy Otezla from Celgene should not deter the drugmaker's stock from gaining ground over the long haul.
Checking Up on 5 Favorite Healthcare REITs
This group benefits from two trends -- declining interest rates and an aging of the population.
Select Medical Holdings Could Soon Resume Its Long-Term Uptrend
Let's review the charts of SEM.
Charts of Alcon Look Good
Traders could go long on the eye-care company on strength above $62 risking below $59 with a $72 price target.